A citation-based method for searching scientific literature

Yi-Chia Lee, Tsung-Hsien Chiang, Chu-Kuang Chou, Yu-Kang Tu, Wei-Chih Liao, Ming-Shiang Wu, David Y Graham. Gastroenterology 2016
Times Cited: 409







List of co-cited articles
614 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Optimum duration of regimens for Helicobacter pylori eradication.
Yuhong Yuan, Alex C Ford, Khurram J Khan, Javier P Gisbert, David Forman, Grigorios I Leontiadis, Frances Tse, Xavier Calvet, Carlo Fallone, Lori Fischbach,[...]. Cochrane Database Syst Rev 2013
124
3

Endoscopic features associated with development of metachronous gastric cancer in patients who underwent endoscopic resection followed by Helicobacter pylori eradication.
Kosaku Moribata, Jun Kato1 Mikitaka Iguchi, Kenichiro Nakachi, Yoshimasa Maeda, Naoki Shingaki, Toru Niwa, Hisanobu Deguchi, Izumi Inoue, Takao Maekita, Hideyuki Tamai,[...]. Dig Endosc 2016
15
20

Eradication of Helicobacter pylori and Gastric Cancer: A Systematic Review and Meta-analysis of Cohort Studies.
Eva Doorakkers, Jesper Lagergren, Lars Engstrand, Nele Brusselaers. J Natl Cancer Inst 2016
52
5

Gastric cancer development after Helicobacter pylori eradication therapy: a new form of gastric neoplasia.
Taiji Matsuo, Masanori Ito, Masana Tatsugami, Tomoyuki Boda, Shunsuke Takata, Shinji Tanaka, Kazuaki Chayama. Digestion 2012
30
10

Effectiveness of Helicobacter pylori eradication in the prevention of primary gastric cancer in healthy asymptomatic people: A systematic review and meta-analysis comparing risk ratio with risk difference.
Takeshi Seta, Yoshimitsu Takahashi, Yoshinori Noguchi, Satoru Shikata, Tatsuya Sakai, Kyoko Sakai, Yukitaka Yamashita, Takeo Nakayama. PLoS One 2017
23
13



Eradication of Helicobacter pylori after endoscopic resection of gastric tumors does not reduce incidence of metachronous gastric carcinoma.
Jeongmin Choi, Sang Gyun Kim, Hyuk Yoon, Jong Pil Im, Joo Sung Kim, Woo Ho Kim, Hyun Chae Jung. Clin Gastroenterol Hepatol 2014
97
3

Histological characteristics of gastric mucosa prior to Helicobacter pylori eradication may predict gastric cancer.
Masaaki Kodama, Kazunari Murakami, Tadayoshi Okimoto, Hisanori Abe, Ryugo Sato, Ryo Ogawa, Kazuhiro Mizukami, Seiji Shiota, Yoshifumi Nakagawa, Wataru Soma,[...]. Scand J Gastroenterol 2013
29
10

Relationship between the degree of endoscopic atrophy of the gastric mucosa and carcinogenic risk.
Hironori Masuyama, Naoto Yoshitake, Takako Sasai, Tetsuya Nakamura, Atsushi Masuyama, Toru Zuiki, Kentaro Kurashina, Mitsuyo Mieda, Keijiro Sunada, Hironori Yamamoto,[...]. Digestion 2015
44
6

Bias in meta-analysis detected by a simple, graphical test.
M Egger, G Davey Smith, M Schneider, C Minder. BMJ 1997
3

Endoscopic atrophic classification before and after H. pylori eradication is closely associated with histological atrophy and intestinal metaplasia.
Masaaki Kodama, Tadayoshi Okimoto, Ryo Ogawa, Kazuhiro Mizukami, Kazunari Murakami. Endosc Int Open 2015
18
16

Surveillance strategy based on the incidence and patterns of recurrence after curative endoscopic submucosal dissection for early gastric cancer.
Byung-Hoon Min, Eun Ran Kim, Kyoung-Mee Kim, Cheol Keun Park, Jun Haeng Lee, Poong-Lyul Rhee, Jae J Kim. Endoscopy 2015
64
4

Effect of a proton pump inhibitor or an H2-receptor antagonist on prevention of bleeding from ulcer after endoscopic submucosal dissection of early gastric cancer: a prospective randomized controlled trial.
Noriya Uedo, Yoji Takeuchi, Takuya Yamada, Ryu Ishihara, Hideharu Ogiyama, Sachiko Yamamoto, Motohiko Kato, Koichi Tatsumi, Eriko Masuda, Chie Tamai,[...]. Am J Gastroenterol 2007
163
3

Incidence of lymph node metastasis from early gastric cancer: estimation with a large number of cases at two large centers.
Takuji Gotoda, Akio Yanagisawa, Mitsuru Sasako, Hiroyuki Ono, Yukihiro Nakanishi, Tadakazu Shimoda, Yo Kato. Gastric Cancer 2000
3

Long-term outcomes of endoscopic submucosal dissection for early gastric cancer: a single-center retrospective study.
Takashi Kosaka, Masaki Endo, Yosuke Toya, Yukito Abiko, Norihiko Kudara, Masaaki Inomata, Toshimi Chiba, Yasuhiro Takikawa, Kazuyuki Suzuki, Tamotsu Sugai. Dig Endosc 2014
99
3


A community-based study of Helicobacter pylori therapy using the strategy of test, treat, retest, and re-treat initial treatment failures.
Yi-Chia Lee, Hui-Min Wu, Tony Hsiu-Hsi Chen, Tzeng-Ying Liu, Han-Mo Chiu, Chun-Chao Chang, Hsiu-Po Wang, Ming-Shiang Wu, Hung Chiang, Meng-Chen Wu,[...]. Helicobacter 2006
39
7


Rational Helicobacter pylori therapy: evidence-based medicine rather than medicine-based evidence.
David Y Graham, Yi-Chia Lee, Ming-Shiang Wu. Clin Gastroenterol Hepatol 2014
213
3


Incidence of lymph node metastasis and the feasibility of endoscopic resection for undifferentiated-type early gastric cancer.
Toshiaki Hirasawa, Takuji Gotoda, Satoshi Miyata, You Kato, Tadakazu Shimoda, Hirokazu Taniguchi, Junko Fujisaki, Takeshi Sano, Toshiharu Yamaguchi. Gastric Cancer 2009
327
3

Helicobacter pylori Eradication for Prevention of Metachronous Recurrence after Endoscopic Resection of Early Gastric Cancer.
Chang Seok Bang, Gwang Ho Baik, In Soo Shin, Jin Bong Kim, Ki Tae Suk, Jai Hoon Yoon, Yeon Soo Kim, Dong Joon Kim. J Korean Med Sci 2015
29
10

Antibiotic resistance among Helicobacter pylori clinical isolates in Lima, Peru.
Kevin F Boehnke, Manuel Valdivieso, Alejandro Bussalleu, Rachael Sexton, Kathryn C Thompson, Soledad Osorio, Italo Novoa Reyes, John J Crowley, Laurence H Baker, Chuanwu Xi. Infect Drug Resist 2017
20
15

Helicobacter pylori antimicrobial resistance and antibiotic consumption in the low-resource Central America setting.
Vivian Ortiz, Dagoberto Estevez-Ordonez, Eleazar Montalvan-Sanchez, Samuel Urrutia-Argueta, Dawn Israel, Uma S Krishna, Judith Romero-Gallo, Keith T Wilson, Richard M Peek, Ricardo Dominguez,[...]. Helicobacter 2019
7
42

Helicobacter pylori amoxicillin heteroresistance due to point mutations in PBP-1A in isogenic isolates.
Mario José Matteo, Gabriela Granados, Martín Olmos, Andrés Wonaga, Mariana Catalano. J Antimicrob Chemother 2008
36
8

High-dose dual therapy is superior to standard first-line or rescue therapy for Helicobacter pylori infection.
Jyh-Chin Yang, Chun-Jung Lin, Hong-Long Wang, Jin-De Chen, John Y Kao, Chia-Tung Shun, Chien-Wei Lu, Bor-Ru Lin, Ming-Jium Shieh, Ming-Chu Chang,[...]. Clin Gastroenterol Hepatol 2015
100
3

Risk factors for failure of Helicobacter pylori therapy--results of an individual data analysis of 2751 patients.
N Broutet, S Tchamgoué, E Pereira, H Lamouliatte, R Salamon, F Mégraud. Aliment Pharmacol Ther 2003
156
3

How to Effectively Use Bismuth Quadruple Therapy: The Good, the Bad, and the Ugly.
David Y Graham, Sun-Young Lee. Gastroenterol Clin North Am 2015
77
3

Five-year survival analysis of surgically resected gastric cancer cases in Japan: a retrospective analysis of more than 100,000 patients from the nationwide registry of the Japanese Gastric Cancer Association (2001-2007).
Hitoshi Katai, Takashi Ishikawa, Kohei Akazawa, Yoh Isobe, Isao Miyashiro, Ichiro Oda, Shunichi Tsujitani, Hiroyuki Ono, Satoshi Tanabe, Takeo Fukagawa,[...]. Gastric Cancer 2018
197
3

Helicobacter pylori infection and the risk of gastric carcinoma.
J Parsonnet, G D Friedman, D P Vandersteen, Y Chang, J H Vogelman, N Orentreich, R K Sibley. N Engl J Med 1991
3


Aspirin and risk for gastric cancer: a population-based case-control study in Sweden.
K Akre, A M Ekström, L B Signorello, L E Hansson, O Nyrén. Br J Cancer 2001
114
3

Inflammation, atrophy, and gastric cancer.
James G Fox, Timothy C Wang. J Clin Invest 2007
532
3

Update on clarithromycin resistance in Helicobacter pylori in Hong Kong and its effect on clarithromycin-based triple therapy.
Q Gu, H H X Xia, J D Wang, W M Wong, A O O Chan, K C Lai, C K Chan, M F Yuen, F M Y Fung, K W Wong,[...]. Digestion 2006
20
15

Clarithromycin-amoxycillin-containing triple therapy: a valid empirical first-line treatment for Helicobacter pylori eradication in Hong Kong?
Ivan F N Hung, Pierre Chan, Sally Leung, Fion S Y Chan, Axel Hsu, David But, Wai Kay Seto, Siu Yin Wong, Chi Kuen Chan, Qing Gu,[...]. Helicobacter 2009
35
8

Gastric cancer risk in patients with premalignant gastric lesions: a nationwide cohort study in the Netherlands.
Annemarie C de Vries, Nicole C T van Grieken, Caspar W N Looman, Mariël K Casparie, Esther de Vries, Gerrit A Meijer, Ernst J Kuipers. Gastroenterology 2008
441
3

Risk of gastric cancer in the second decade of follow-up after Helicobacter pylori eradication.
Susumu Take, Motowo Mizuno, Kuniharu Ishiki, Chiaki Kusumoto, Takayuki Imada, Fumihiro Hamada, Tomowo Yoshida, Kenji Yokota, Toshiharu Mitsuhashi, Hiroyuki Okada. J Gastroenterol 2020
36
8

Helicobacter pylori and Antibiotic Resistance, A Continuing and Intractable Problem.
Yue Hu, Meng Zhang, Bin Lu, Jinfeng Dai. Helicobacter 2016
62
4


The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients.
Vyara Matson, Jessica Fessler, Riyue Bao, Tara Chongsuwat, Yuanyuan Zha, Maria-Luisa Alegre, Jason J Luke, Thomas F Gajewski. Science 2018
3

Baseline gut microbiota predicts clinical response and colitis in metastatic melanoma patients treated with ipilimumab.
N Chaput, P Lepage, C Coutzac, E Soularue, K Le Roux, C Monot, L Boselli, E Routier, L Cassard, M Collins,[...]. Ann Oncol 2017
526
3

Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota.
Marie Vétizou, Jonathan M Pitt, Romain Daillère, Patricia Lepage, Nadine Waldschmitt, Caroline Flament, Sylvie Rusakiewicz, Bertrand Routy, Maria P Roberti, Connie P M Duong,[...]. Science 2015
3

Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients.
V Gopalakrishnan, C N Spencer, L Nezi, A Reuben, M C Andrews, T V Karpinets, P A Prieto, D Vicente, K Hoffman, S C Wei,[...]. Science 2018
3

Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors.
Bertrand Routy, Emmanuelle Le Chatelier, Lisa Derosa, Connie P M Duong, Maryam Tidjani Alou, Romain Daillère, Aurélie Fluckiger, Meriem Messaoudene, Conrad Rauber, Maria P Roberti,[...]. Science 2018
3

The prevalence of Helicobacter pylori in peptic ulcer disease.
E J Kuipers, J C Thijs, H P Festen. Aliment Pharmacol Ther 1995
308
3

Diagnosis of Helicobacter pylori infection : A short review.
Ante Tonkic, Jonatan Vukovic, Pavle Vrebalov Cindro, Valdi Pesutic Pisac, Marija Tonkic. Wien Klin Wochenschr 2018
11
27

Interleukin-1 polymorphisms associated with increased risk of gastric cancer.
E M El-Omar, M Carrington, W H Chow, K E McColl, J H Bream, H A Young, J Herrera, J Lissowska, C C Yuan, N Rothman,[...]. Nature 2000
3

Campylobacter pylori detected noninvasively by the 13C-urea breath test.
D Y Graham, P D Klein, D J Evans, D G Evans, L C Alpert, A R Opekun, T W Boutton. Lancet 1987
687
3

Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes.
Razvan Cristescu, Jeeyun Lee, Michael Nebozhyn, Kyoung-Mee Kim, Jason C Ting, Swee Seong Wong, Jiangang Liu, Yong Gang Yue, Jian Wang, Kun Yu,[...]. Nat Med 2015
3


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.